Zhou SL - Search Results

1

Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 (MALAT1) interacts with estrogen receptor and predicted poor survival in breast cancer.

Huang NS, Chi YY, Xue JY, Liu MY, Huang S, Mo M, Zhou SL, Wu J. Huang NS, et al. Among authors: zhou sl. Oncotarget. 2016 Jun 21;7(25):37957-37965. doi: 10.18632/oncotarget.9364. Oncotarget. 2016. PMID: 27191888 Free PMC article.

2

Role of BC040587 as a predictor of poor outcome in breast cancer.

Chi Y, Huang S, Yuan L, Liu M, Huang N, Zhou S, Zhou B, Wu J. Chi Y, et al. Cancer Cell Int. 2014 Nov 26;14(1):123. doi: 10.1186/s12935-014-0123-7. eCollection 2014. Cancer Cell Int. 2014. PMID: 25435812 Free PMC article.

3

Clinicopathologic Characteristics of Oestrogen Receptor-Positive/Progesterone Receptor-Negative/Her2-Negative Breast Cancer According to a Novel Definition of Negative Progesterone Receptor Status: A Large Population-Based Study from China.

Li AQ, Zhou SL, Li M, Xu Y, Shui RH, Yu BH, Yang WT. Li AQ, et al. Among authors: zhou sl. PLoS One. 2015 May 4;10(5):e0125067. doi: 10.1371/journal.pone.0125067. eCollection 2015. PLoS One. 2015. PMID: 25938238 Free PMC article.

4

HDAC5, a potential therapeutic target and prognostic biomarker, promotes proliferation, invasion and migration in human breast cancer.

Li A, Liu Z, Li M, Zhou S, Xu Y, Xiao Y, Yang W. Li A, et al. Oncotarget. 2016 Jun 21;7(25):37966-37978. doi: 10.18632/oncotarget.9274. Oncotarget. 2016. PMID: 27177225 Free PMC article.

5

Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer.

Li M, Li A, Zhou S, Xu Y, Xiao Y, Bi R, Yang W. Li M, et al. BMC Cancer. 2018 Jan 2;18(1):4. doi: 10.1186/s12885-017-3916-y. BMC Cancer. 2018. PMID: 29291717 Free PMC article.

6

CAPG enhances breast cancer metastasis by competing with PRMT5 to modulate STC-1 transcription.

Huang S, Chi Y, Qin Y, Wang Z, Xiu B, Su Y, Guo R, Guo L, Sun H, Zeng C, Zhou S, Hu X, Liu S, Shao Z, Wu Z, Jin W, Wu J. Huang S, et al. Theranostics. 2018 Apr 3;8(9):2549-2564. doi: 10.7150/thno.22523. eCollection 2018. Theranostics. 2018. PMID: 29721098 Free PMC article.

7

Impact of the Updated 2018 American Society of Clinical Oncology/College of American Pathologists Guideline for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer.

Li A, Bai Q, Kong H, Zhou S, Lv H, Zhong S, Li M, Bi R, Zhou X, Yang W. Li A, et al. Arch Pathol Lab Med. 2020 Sep 1;144(9):1097-1107. doi: 10.5858/arpa.2019-0369-OA. Arch Pathol Lab Med. 2020. PMID: 32142367 Free article.

8

RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.

Li M, Li AQ, Zhou SL, Lv H, Wei P, Yang WT. Li M, et al. Among authors: zhou sl. J Exp Clin Cancer Res. 2020 May 24;39(1):92. doi: 10.1186/s13046-020-01587-x. J Exp Clin Cancer Res. 2020. PMID: 32448269 Free PMC article.

9

HER2-low breast cancer: evolution of HER2 expression from primary tumor to distant metastases.

Cai M, Li M, Lv H, Zhou S, Xu X, Shui R, Yang W. Cai M, et al. BMC Cancer. 2023 Jul 13;23(1):656. doi: 10.1186/s12885-023-11134-4. BMC Cancer. 2023. PMID: 37442945 Free PMC article.

10

[Metastases to the breast from non-mammary malignancies: a clinicopathologic study of 28 cases].

Zhou S, Yu B, Cheng Y, Xu X, Shui R, Bi R, Lu H, Tu X, Yang W. Zhou S, et al. Zhonghua Bing Li Xue Za Zhi. 2014 Apr;43(4):231-5. Zhonghua Bing Li Xue Za Zhi. 2014. PMID: 24915812 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

391 results

Search Page

Filters